Online citations, reference lists, and bibliographies.

Epigenetic Modifications In Head And Neck Cancer

Jadwiga Gaździcka, Karolina Gołąbek, Joanna Katarzyna Strzelczyk, Zofia Ostrowska
Published 2019 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common human malignancy in the world, with high mortality and poor prognosis for patients. Among the risk factors are tobacco and alcohol intake, human papilloma virus, and also genetic and epigenetic modifications. Many studies show that epigenetic events play an important role in HNSCC development and progression, including DNA methylation, chromatin remodeling, histone posttranslational covalent modifications, and effects of non-coding RNA. Epigenetic modifications may influence silencing of tumor suppressor genes by promoter hypermethylation, regulate transcription by microRNAs and changes in chromatin structure, or induce genome instability through hypomethylation. Moreover, getting to better understand aberrant patterns of methylation may provide biomarkers for early detection and diagnosis, while knowledge about target genes of microRNAs may improve the therapy of HNSCC and extend overall survival. The aim of this review is to present recent studies which demonstrate the role of epigenetic regulation in the development of HNSCC.
This paper references
10.1016/j.bbrc.2019.02.057
The long noncoding RNA ST7-AS1 promotes laryngeal squamous cell carcinoma by stabilizing CARM1.
Haiping Qin (2019)
Bradford CR et al (2015) NDN and CD1A are novel prognostic methylation
S Virani (2015)
10.1038/nature19081
Tumor hypoxia causes DNA hypermethylation by reducing TET activity
Bernard Thienpont (2016)
10.1158/1078-0432.CCR-12-2505
Dysregulation of the Repressive H3K27 Trimethylation Mark in Head and Neck Squamous Cell Carcinoma Contributes to Dysregulated Squamous Differentiation
Orla Margaret Gannon (2012)
10.1016/j.anl.2018.10.020
MiR-196b affects the progression and prognosis of human LSCC through targeting PCDH-17.
Min Luo (2019)
10.3390/cells8080772
Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis
Chellan Kumarasamy (2019)
10.1080/21691401.2019.1647222
MiR-638 suppresses the progression of oral squamous cell carcinoma through wnt/β-catenin pathway by targeting phospholipase D1
Kai-liang Tang (2019)
Long non - coding RNA C 5 orf 66 - AS 1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis
T Lu (2018)
10.1080/21691401.2019.1576712
MiR-29a inhibits the progression of oral squamous cell carcinoma by targeting Wnt/β-catenin signalling pathway
Chao Huang (2019)
10.1016/S0092-8674(04)00045-5
MicroRNAs Genomics, Biogenesis, Mechanism, and Function
D. Bartel (2004)
10.18632/oncotarget.25333
Association of TET3 epigenetic inactivation with head and neck cancer
Kiyoshi Misawa (2018)
Downregulation of CEACAM6 gene expression in laryngeal squamous cell carcinoma is an effect of DNA hypermethylation and correlates with disease progression.
Kinga Bednarek (2018)
10.1186/s13073-017-0419-z
Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
Davide Degli Esposti (2017)
10.1016/j.gene.2017.12.049
MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7.
Min-Da Liu (2018)
10.1007/s13277-015-3038-6
Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma
G. Li (2015)
10.1158/1078-0432.CCR-08-3131
MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma
Michele Avissar (2009)
10.1158/1078-0432.CCR-08-3053
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Jinsong Li (2009)
10.3892/or.2016.5236
Non-coding RNAs as regulators in epigenetics (Review).
Jianwei Wei (2017)
10.1038/cr.2011.22
Regulation of chromatin by histone modifications
Andrew J. Bannister (2011)
10.1016/j.prp.2017.02.003
Hypoxia reduces the E-cadherin expression and increases OSCC cell migration regardless of the E-cadherin methylation profile.
Patrícia Luciana Batista Domingos (2017)
Cancer epigenetics. Oncogene 22:6479–6483
RL Momparler (2003)
10.1371/journal.pone.0159693
Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target
Hirohiko Tachibana (2016)
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
M. Sánchez-Céspedes (2000)
10.1016/j.molmed.2007.07.004
Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling.
G. Wang (2007)
10.3892/OR.19.6.1429
PTEN expression and methylation status in oral squamous cell carcinoma.
Yoshinori Kurasawa (2008)
10.3390/cells8040366
Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas
Tomasz Kolenda (2019)
10.1097/CCO.0000000000000444
Tobacco and alcohol-induced epigenetic changes in oral carcinoma
Yasmine Ghantous (2018)
10.3892/ijo.2019.4707
lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β-catenin pathway in oral squamous cell carcinoma
Fubo Chen (2019)
Aberrant promoter methylation of PTEN gene
NS Alyasiri (2013)
10.1038/labinvest.2014.123
Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer
Z. Li (2014)
10.3389/fonc.2019.00342
Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors
J. Zhang (2019)
10.1007/s00795-017-0156-9
Immunohistochemical evaluation of Klotho and DNA methyltransferase 3a in oral squamous cell carcinomas
Bhoj Raj Adhikari (2017)
10.1007/s13353-017-0404-7
Prognostic potential of KLOTHO and SFRP1 promoter methylation in head and neck squamous cell carcinoma
Abeer A Alsofyani (2017)
10.1080/23723548.2014.954827
Predictive value of epigenetic alterations in head and neck squamous cell carcinoma
Jennifer Koffler (2014)
10.5772/51169
DNA Methylation in the Pathogenesis of Head and Neck Cancer
Zvonko Magić (2012)
2016) MiR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma
Lu W-C (2016)
10.1111/jop.12892
Long non-coding RNA myocardial infarction associated transcript promotes epithelial-mesenchymal transition and is an independent risk factor for poor prognosis of tongue squamous cell carcinoma.
W. Zhong (2019)
10.1056/NEJMra023075
Gene silencing in cancer in association with promoter hypermethylation.
J. Herman (2003)
10.1016/j.canlet.2013.05.032
miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII.
Ting-Hui Chu (2013)
10.1007/s12253-018-0542-1
Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics
Abdolamir Allameh (2018)
10.1002/cbf.3233
RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Su Jili (2016)
2018b) The long noncoding RNA TUG1 promotes laryngeal cancer
Z Zhang (2018)
Non-coding RNAs as regulators in epigenetics
Wei J-W (2017)
10.1007/s13148-011-0032-8
Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications
Nakarin Kitkumthorn (2011)
10.4252/wjsc.v6.i5.511
Histone modifications: Targeting head and neck cancer stem cells.
J. M. Le (2014)
10.1126/science.1170116
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani (2009)
10.18632/ONCOTARGET.2684
Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma
Xiao-yun Zhang (2015)
10.1007/s00784-016-1772-9
Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients
Gordana Supic (2016)
The miR - 2055 p / BRCA 1 / RAD 17 axis promotes genomic instability in head and neck squamous cell carcinomas
van Kempen PMW (2014)
2018a) Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma
S Hu (2018)
10.1186/s12885-016-2468-x
Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines
Li-Hsuen Chen (2016)
10.1016/j.ajpath.2011.01.043
Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.
F. Fang (2011)
10.1016/j.celrep.2017.06.020
DOC1-Dependent Recruitment of NURD Reveals Antagonism with SWI/SNF during Epithelial-Mesenchymal Transition in Oral Cancer Cells.
Adone Mohd-Sarip (2017)
Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers.
Qingqing Yang (2014)
10.5037/jomr.2013.4102
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
Dan Dan Chen (2013)
10.1007/s12032-013-0513-z
High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan
Jen-Hao Chen (2013)
10.1002/2211-5463.12478
Biological role and clinical value of miR‐99a‐5p in head and neck squamous cell carcinoma (HNSCC): A bioinformatics‐based study
Yuting Chen (2018)
10.1186/s13148-017-0357-z
Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma
C. Furlan (2017)
10.1111/jop.12381
Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma.
Hung-Chih Chen (2016)
10.1007/s13148-011-0045-3
Role of DNA methylation in head and neck cancer
Semra Demokan (2011)
10.7150/jca.26465
LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck
Changyun Yu (2018)
10.1007/s13277-015-4648-8
PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population
Pinninti Santosh Sushma (2015)
10.1186/s13072-019-0283-8
Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma
Baoshan Wang (2019)
10.3892/or_00000107
Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.
Xiaojun Ding (1994)
10.1093/carcin/bgp277
MicroRNA expression in head and neck cancer associates with alcohol consumption and survival.
Michele Avissar (2009)
10.1016/j.prp.2016.02.022
Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer.
Ozlem Onerci Celebi (2016)
10.3390/ijms19123707
Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
Daiki Mochizuki (2018)
10.1371/journal.pone.0004941
Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability
Kristy L Richards (2009)
Long noncoding RNA: genome organization and mechanism
VS Akhade (2017)
10.18632/oncotarget.11138
miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma
Wen-cheng Lu (2016)
10.1111/his.13218
Hypoacetylation of acetyl‐histone H3 (H3K9ac) as marker of poor prognosis in oral cancer
Liana Preto Webber (2017)
10.4103/0970-9290.152208
Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.
Kulasiri Don (2014)
10.1002/jcb.26236
Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
Wei Wang (2018)
10.1016/j.cellsig.2017.10.009
Emerging role of non-coding RNA in oral cancer.
Fatemeh Momen-Heravi (2018)
10.1080/2162402X.2018.1452579
Detailed analysis of adenosine A2a receptor (ADORA2A) and CD73 (5′-nucleotidase, ecto, NT5E) methylation and gene expression in head and neck squamous cell carcinoma patients
Timo J. Vogt (2018)
10.1016/j.oraloncology.2012.02.020
Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma.
Zujian Chen (2012)
10.1017/CBO9781139046947
Molecular Oncology: Causes of Cancer and Targets for Treatment
Edward P. Gelmann (2013)
10.1186/s12935-019-0838-6
HOXA11-AS promotes the progression of oral squamous cell carcinoma by targeting the miR-518a-3p/PDK1 axis
B. Li (2019)
10.1002/jso.25278
Long noncoding RNA LINC01133 inhibits oral squamous cell carcinoma metastasis through a feedback regulation loop with GDF15
Jianlu Kong (2018)
10.1111/odi.12133
MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer.
Yihsiang Kuo (2014)
10.1016/j.oraloncology.2014.02.015
Methylation as a biomarker for head and neck cancer.
Lídia M R B Arantes (2014)
10.7150/jca.23527
Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer
Kiyoshi Misawa (2018)
10.1186/s13148-017-0386-7
CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel
L. Morandi (2017)
10.7150/jca.24477
Aberrant DNA methylation of the p16, APC, MGMT, TIMP3 and CDH1 gene promoters in tumours and the surgical margins of patients with oral cavity cancer
Joanna Katarzyna Strzelczyk (2018)
10.1016/j.biopha.2019.109222
LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis.
Zhenxing Xu (2019)
miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review
Soussan Irani (2016)
10.1093/hmg/ddi113
Cancer epigenetics.
P. Laird (2005)
10.1002/jcla.22899
ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
Z. Shen (2019)
10.1016/S0955-0674(02)00335-6
The many faces of histone lysine methylation.
M. Lachner (2002)
Expression of long non-coding RNA HOXA11-AS is correlated with progression of laryngeal squamous cell carcinoma.
Lingmei Qu (2018)
10.1042/BSR20181882
MicroRNA-625 inhibits cell invasion and epithelial–mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma
Yuan Li (2019)
miR-125a-5p functions as tumor suppressor microRNA and is a marker of locoregional recurrence and poor prognosis in head and neck cancer. Neoplasia 21:849–862
DT Vo (2019)
10.5772/59826
New Aspects in Molecular and Cellular Mechanisms of Human Carcinogenesis
Dmitry Bulgin (2016)
miR - 125 a - 5 p functions as tumor suppressor microRNA and is a marker of locoregional recurrence and poor prognosis in head and neck cancer
DT Vo
Molecular genetics and biology of head and neck squamous cell carcinoma: Implications for diagnosis, prognosis and treatment. In: Agulnik M (ed) Head and neck cancer
F Ganci (2012)
MiR - 34 a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma ( HNSCC )
Zhang X-Y
10.1016/j.oraloncology.2017.07.030
Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma.
Swati Shree Padhi (2017)
10.3892/ijmm.2018.3913
Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis
Tianzhu Lu (2018)
10.5772/2932
Methylation - From DNA, RNA and Histones to Diseases and Treatment
Anica Dricu (2012)
10.18388/ABP.2009_2473
H3K4 histone methylation in oral squamous cell carcinoma.
Marta Mancuso (2009)
10.1158/2159-8290.CD-16-1292
The Epitranscriptome of Noncoding RNAs in Cancer.
M. Esteller (2017)
10.1002/IJC.22889
DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage.
I. E. M. Smith (2007)
10.1007/978-3-7643-8989-5_2
Genome-wide epigenetic modifications in cancer.
Yoon Jung Park (2011)
10.1016/j.prp.2017.04.016
The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Yi Wang (2017)
nosis in early-stage laryngeal squamous cell carcinoma
J Zhang (2018)
10.1002/ijc.28906
Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients.
Rolf Warta (2014)
Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carci
T Lu (2018)
10.1038/onc.2011.660
Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma
Jittiporn Chaisaingmongkol (2012)
10.1016/j.oraloncology.2008.05.002
Detection of LINE-1s hypomethylation in oral rinses of oral squamous cell carcinoma patients.
K. Subbalekha (2009)
10.1016/j.ymthe.2018.09.018
Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1
W. Gao (2019)
10.5301/JBM.5000030
Aberrant Promoter Methylation of PTEN Gene among Indian Patients with Oral Squamous Cell Carcinoma
Nisreen Sherif Alyasiri (2013)
10.3390/ijms18071506
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
Rogerio Moraes Castilho (2017)
10.1007/s11010-016-2690-5
Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis
Bhawna Rastogi (2016)
10.22034/APJCP.2018.19.4.1053
Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma
P. Singh (2018)
10.1080/15384047.2017.1416276
Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma
Yan Guo (2018)
10.3390/cancers11091347
The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas
Fabio Valenti (2019)
The clinical significance of promoter hypermethylation in head and neck squamous cell carcinoma
C Zhou (2019)
10.1017/CBO9781139046947.006
Molecular Oncology: DNA methylation
Marsha Reyngold (2013)
10.3892/ol.2017.7661
Downregulated cytoplasmic polyadenylation element-binding protein-4 is associated with the carcinogenesis of head and neck squamous cell carcinoma.
Manli Zeng (2018)
10.1002/jcb.27753
microRNA‐211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein
Jiabao Zheng (2019)
10.1080/15384101.2018.1526601
Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma
Shousen Hu (2018)
Identification and validation of WISP 1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma
MJAM Clausen (2016)
SnapShot: chromatin remodeling complexes. Cell 129:632.e1–632.e2
Y doi.org10.1038cr.2011.22 Bao (2007)
The long noncoding RNA TUG 1 promotes laryngeal cancer proliferation and migration
Z Zheng (2019)
10.1186/s13148-017-0314-x
Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India
Baidehi Basu (2017)
10.1074/jbc.M112.425736
Oncogenic MicroRNA-155 Down-regulates Tumor Suppressor CDC73 and Promotes Oral Squamous Cell Carcinoma Cell Proliferation
Mohammad Iqbal Rather (2012)
10.3892/mmr.2012.971
Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
Bin Yan (2012)
10.4161/epi.29025
Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer
R. Guerrero-Preston (2014)
10.7150/jca.29029
Knockdown of LncRNA RHPN1-AS1 Inhibits Cell Migration, Invasion and Proliferation in Head and Neck Squamous Cell Carcinoma
Xiao-wen Qiu (2019)
10.1186/s12885-019-6021-6
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma
Madeleine Sassenberg (2019)
10.3892/or.2012.1624
Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: Pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells
Dimitrios Koutsimpelas (2012)
10.1016/j.biocel.2008.04.026
SWI/SNF: a chromatin-remodelling complex with a role in carcinogenesis.
Gary M Halliday (2009)
10.3892/ijo.31.3.517
Overexpression of small ubiquitin-related modifier-1 and sumoylated Mdm2 in oral squamous cell carcinoma: possible involvement in tumor proliferation and prognosis.
Akihiro Katayama (2007)
2018b) A novel long non-coding RNA, AC012456.4, as a valuable and independent prognostic biomarker of survival in oral squamous cell carcinoma
X Hu (2018)
10.1111/jcmm.14107
MicroRNA‐224, negatively regulated by c‐jun, inhibits growth and epithelial‐to‐mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma
Yaoyong Lu (2019)
10.1007/978-981-10-5203-3_2
Long Noncoding RNA: Genome Organization and Mechanism of Action.
Vijay Suresh Akhade (2017)
10.1002/jcla.22873
The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
Chongchang Zhou (2019)
10.18632/ONCOTARGET.1875
Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer
U. Bedi (2014)
10.1002/cam4.313
HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation
P. M. W. van Kempen (2014)
10.1016/j.molmed.2007.07.003
Chromatin remodeling and cancer, Part I: Covalent histone modifications.
G. Wang (2007)
10.1042/BST0370918
miR-21 as a key regulator of oncogenic processes.
S. Duygu Selcuklu (2009)
10.7314/APJCP.2012.13.9.4469
LINE-1 and Alu methylation patterns in lymph node metastases of head and neck cancers.
Nakarin Kitkumthorn (2012)
10.1371/journal.pone.0163534
Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis
Fucheng Cai (2016)
10.1007/s00280-008-0833-4
Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells
Maiko Suzuki (2008)
10.1016/j.molcel.2011.08.018
Molecular mechanisms of long noncoding RNAs.
K. Wang (2011)
10.1101/365205
Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy
Ratna Veeramachaneni (2018)
10.1016/j.tibs.2016.07.003
Linking Long Noncoding RNA Localization and Function.
L. Chen (2016)
10.1177/039463201002300427
MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression
Luca Scapoli (2010)
10.1242/jcs.010389
The RASSF1A tumor suppressor
H. Donninger (2007)
10.1002/ijc.28358
miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
Chung-Ji Liu (2014)
Alu hypomethylation in smoke
C Puttipanyalears (2013)
2019b) MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma
Y Li (2019)
Long non - coding RNA C 5 orf 66 - AS 1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis
W Huang (2019)
10.3892/or.2014.3061
Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
Jinbang Li (2014)
10.1016/j.fob.2013.12.003
NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)☆
Luciana Oliveira Almeida (2014)
10.1155/2019/8645153
LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression
Xiaoyan Wang (2019)
10.1186/s12885-015-1806-8
NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas
Shama Virani (2015)
MiR-31 is a potential biomarker for diagnosis of head and neck squamous cell carcinoma.
Longlong Wang (2018)
10.1002/jcp.26833
MicroRNA‐16 functions as a tumor‐suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2
X. Wang (2018)
10.1111/jop.12351
MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
O. Baba (2016)
10.1007/s00428-017-2094-2
Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue
S. Bhat (2017)
10.1016/j.prp.2019.02.002
Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Gan-Guan Wei (2019)
10.5772/31956
Molecular Genetics and Biology of Head and Neck Squamous Cell Carcinoma: Implications for Diagnosis, Prognosis and Treatment
Federica Ganci (2012)
2015a) MiR-34a suppresses amphiregulin and tumor metastatic
Y Wang (2015)
2014b) The prognostic value of global DNA hypomethylation in cancer: a meta-analysis
J Li (2014)
10.1002/mc.22808
Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation
Ewa Byzia (2018)
10.1177/1010428317691427
Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma
Marcin Szaumkessel (2017)
10.7314/APJCP.2015.16.4.1615
BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
Anandh Balasubramanian (2015)
10.1371/journal.pone.0037601
Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis
Bhavna Kumar (2012)
10.1111/jcmm.13987
Long non‐coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR‐197/LIN28 axis
Jie Wu (2019)
10.4161/epi.6.3.14182
Hypermethylation of multiple tumor-related genes associated with DMNT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma
Bo Li (2011)
10.1002/cncr.28356
Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma.
Yawei Chen (2013)
10.1038/s41598-018-21659-5
Long non-coding RNA AC026166.2-001 inhibits cell proliferation and migration in laryngeal squamous cell carcinoma by regulating the miR-24-3p/p27 axis
Z. Shen (2018)
10.1007/s00428-006-0360-9
Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer
Guangying Qi (2006)
10.1007/s00018-010-0624-z
Epigenetic aberrations during oncogenesis
Maria Hatziapostolou (2010)
10.2217/epi.09.33
DNA hypomethylation in cancer cells.
M. Ehrlich (2009)
10.1371/journal.pone.0129808
Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics
J. H. Choudhury (2015)
10.2967/jnumed.111.089623
mTOR Signaling, Function, Novel Inhibitors, and Therapeutic Targets
R. Watanabe (2011)
10.3892/IJO.2019.4784
TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis
Weina Cui (2019)
10.12659/MSM.904751
The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma
Zhisen Shen (2017)
10.1101/gad.276568.115
Role of TET enzymes in DNA methylation, development, and cancer.
Kasper Dindler Rasmussen (2016)
10.1007/S41548-018-0003-2
Loss of ARID1A, a component of the SWI/SNF chromatin remodeling complex, at the invasion front is related to poor outcomes in oral squamous cell carcinoma
Keisuke Inoue (2018)
10.18632/ONCOTARGET.4281
TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma
A. Murata (2015)
10.1016/j.oooo.2012.12.013
SIRT1 expression is associated with good prognosis for head and neck squamous cell carcinoma patients.
A. Noguchi (2013)
10.1016/j.cell.2007.04.018
SnapShot: Chromatin Remodeling Complexes
Yunhe Bao (2007)
10.7314/APJCP.2013.14.9.5495
Alu hypomethylation in smoke-exposed epithelia and oral squamous carcinoma.
Charoenchai Puttipanyalears (2013)
10.1186/s13148-019-0715-0
Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC)
Soo Yeon Kim (2019)
10.1016/j.molimm.2005.11.010
DNA methylation and apoptosis.
Gopal Gopisetty (2006)
The long noncoding RNA TUG 1 promotes laryngeal cancer proliferation and migration
J Zhang (2019)
High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas
木谷 憲典 (2009)
10.1159/000493876
The Long Noncoding RNA TUG1 Promotes Laryngeal Cancer Proliferation and Migration
Zhonghua Zhang (2018)
10.1155/2019/2682657
The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus
Jie Wang (2019)
10.1002/ijc.31638
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Shih-Yuan Peng (2018)
10.18632/oncotarget.23080
PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas
Alina Franzen (2018)
10.1371/journal.pone.0106290
The Prognostic Value of Global DNA Hypomethylation in Cancer: A Meta-Analysis
Jinhui Li (2014)
10.3892/OR_00000804
Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
Sotai Kimura (2010)
10.1038/jhg.2013.63
Tet family of 5-methylcytosine dioxygenases in mammalian development
H. Zhao (2013)
10.18632/ONCOTARGET.3148
MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC)
J. Zhang (2015)
10.1016/j.drup.2004.06.005
Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
J. Teodoridis (2004)
10.1038/sj.bjc.6604948
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
H-C Chen (2009)
10.3892/ijo.29.1.117
Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
T. Sakuma (2006)
10.1002/jcb.26902
Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.
S. Yang (2018)
10.1371/journal.pone.0173194
Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis
Fucheng Cai (2017)
10.1097/MD.0000000000009971
Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk
Guohong Wen (2018)
10.1186/s13046-019-1283-z
MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1
Sung-Tau Chou (2019)
and disease
Tang K-L
2016) MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis
O Baba (2016)
Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma.
Y. Zhang (2016)
10.1158/1940-6207.CAPR-14-0179
New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development
Jean-Philippe Foy (2015)
10.1016/j.neo.2019.06.004
miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer1
D. T. Vo (2019)
10.1146/annurev.med.59.053006.104707
MicroRNAs in Cancer.
R. Garzon (2009)
10.2174/1568009613666131126115012
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Giuseppe Pannone (2014)
10.1097/MD.0000000000009971
Associations of RASSF1A, RAR&bgr;, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis
Guohong Wen (2018)
10.1016/j.archoralbio.2018.12.001
Methylation status of SFRP1, SFRP2, RASSF1A, RARβ and DAPK1 genes in patients with oral squamous cell carcinoma.
Joanna Katarzyna Strzelczyk (2019)
10.1371/journal.pone.0054742
Comprehensive Analysis of DNA Methylation in Head and Neck Squamous Cell Carcinoma Indicates Differences by Survival and Clinicopathologic Characteristics
Justin A Colacino (2013)
10.3390/cancers2020653
MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
Masashi Shiiba (2010)
10.1007/s00394-017-1411-5
Methyl-donor depletion of head and neck cancer cells in vitro establishes a less aggressive tumour cell phenotype
Vanessa Hearnden (2017)
Association of TET 3 epigenetic inactivation with head and neck cancer
K Misawa
10.1371/journal.pone.0058672
Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer
Fernanda Salgueiredo Giudice (2013)
10.1002/gcc.22310
Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
Martijn J. A. M. Clausen (2016)
10.1021/cr500350x
Post-Translational Modifications of Histones That Influence Nucleosome Dynamics
Gregory D Bowman (2015)
10.1186/s12929-019-0506-0
Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma
W. Meng (2019)
10.2147/CMAR.S171796
Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma
J. Zhang (2018)
The role of DNA methylation in cancer development.
M. Luczak (2006)
10.1038/srep20756
Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis
Ruiwei Meng (2016)
10.1080/15384047.2017.1323585
Elevation of MiR-9–3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV
Y. Ding (2017)
10.1016/j.stem.2010.08.002
Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.
Martin Sauvageau (2010)
10.1159/000494473
The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis
Chongchang Zhou (2018)
10.1038/cr.2008.24
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
S. Zhu (2008)
Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma.
Fredrik Jäwert (2013)
10.1016/j.canlet.2019.04.028
MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma.
Yu-Yu Kao (2019)
10.18632/aging.102000
Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma
Wenguang Xu (2019)
10.1016/j.oraloncology.2008.08.011
Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients.
Hao-Hueng Chang (2009)
10.1002/1878-0261.12352
MicroRNA‐9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4
Hersi Mohamed Hersi (2018)
10.1016/j.jcms.2018.07.019
Promotor hypermethylated genes: Prospective diagnostic biomarkers in oral cancerogenesis.
Suzana Dvojakovska (2018)
10.5772/61135
Epigenetic Mechanisms in Head and Neck Cancer
Julio César Mejía Osorio (2016)
2018a) MiR-31 is a potential biomarker for diagnosis of head and neck squamous cell carcinoma
Wang L-L (2018)
10.7717/peerj.5307
A novel long non-coding RNA, AC012456.4, as a valuable and independent prognostic biomarker of survival in oral squamous cell carcinoma
Xuegang Hu (2018)
10.1111/odi.12944
Head and neck squamous cell carcinoma drives long interspersed element-1 hypomethylation in the peripheral blood mononuclear cells.
Areeya Arayataweegool (2019)
Molecular biology of head and neck cancer.
David G. Brachman (1994)
10.1158/0008-5472.CAN-17-3091
PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.
Chengli Song (2018)
10.1242/dev.070771
Tet family proteins and 5-hydroxymethylcytosine in development and disease
L. Tan (2012)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar